agilon health, inc. provided revenue guidance for the first quarter ending March 31, 2024. For the quarter, the company expects total revenues of $1,605 million to $1,630 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.4 USD | +4.05% | +10.14% | -57.61% |
04:37pm | Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating | MT |
05-07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.61% | 2.13B | |
-17.30% | 3.07B | |
-12.96% | 2.96B | |
-27.10% | 322M | |
+5.57% | 233M | |
-46.75% | 171M | |
-32.40% | 115M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2024